GumnitRJ. The epilepsy handbook. New York: Raven Press, 1983:1–12.
2.
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia1985; 26: 268–78.
3.
PenryJK, ed. Epilepsy: Diagnosis, management, quality of life. New York: Raven Press, 1986:35–6.
4.
WeltyTEGravesNMCloydJC. Antiepileptic drug therapy: Fine tuning the dosage regimen. Postgrad Med1983; 74: 287–305.
5.
AlbrightPSBruniJ. Antiepileptic drug interactions. Can J Neurol Sci1984; 11: 247–51.
6.
ReynoldsEHShorvonD. Monotherapy or polytherapy for epilepsy. Epilepsia1981; 22: 1–10.
7.
EadieMJ. Which anticonvulsant drug?Drugs1979; 17: 213–8.
8.
HolowachJThurstonDLO'LearyJ. Prognosis in childhood epilepsy. Follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control. N Engl J Med1972; 286: 169–74.
9.
Holowach-ThurstonJThurstonDLHixonBBKellerAJ. Prognosis in childhood epilepsy. Additional follow-up of 148 children 15 to 23 years after withdrawal of anti-convulsant therapy. N Engl J Med1982; 306: 831–6.
10.
MattsonRHCramerJACollinsJF. Comparison of carbamazepine, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med1985; 313: 145–51.
11.
WilderBJRangelRJ. Review of valproate monotherapy in the treatment of generalized tonic-clonic seizures. Am J Med1988; 84 (suppl 1A): 7–13.
12.
TrimbleMR. Anticonvulsant drugs and cognitive function: A review of literature. Epilepsia1987; 28 (suppl 3): S37–45.
13.
American Association of Pediatrics. Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics1985; 76: 644–7.
